A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)

NCT03671148 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

444

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis (PsA)

Interventions

BIOLOGICAL: Placebo
BIOLOGICAL: Risankizumab

Sponsor

AbbVie